FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

443763005: Pazopanib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2010. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2836585010 Pazopanib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2840747015 Pazopanib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pazopanib (substance) Is a Protein-tyrosine kinase inhibitor true Inferred relationship Some
Pazopanib (substance) Has disposition (attribute) Protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Some
Pazopanib (substance) Is a Chemical categorized functionally false Inferred relationship Some
Pazopanib (substance) Is a Enzyme inhibitor false Inferred relationship Some
Pazopanib (substance) Is a Sulfonamide (substance) true Inferred relationship Some
Pazopanib (substance) Is a Aminopyrimidine (substance) true Inferred relationship Some
Pazopanib (substance) Is a Indazole (substance) true Inferred relationship Some
Pazopanib (substance) Has disposition (attribute) Vascular endothelial growth factor receptor antagonist (disposition) true Inferred relationship Some
Pazopanib (substance) Is a Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Some
Pazopanib (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing pazopanib (medicinal product) Has active ingredient True Pazopanib (substance) Inferred relationship Some 1
Product containing precisely pazopanib 200 milligram/1 each conventional release oral tablet Has active ingredient False Pazopanib (substance) Inferred relationship Some
Product containing precisely pazopanib 400 milligram/1 each conventional release oral tablet Has active ingredient False Pazopanib (substance) Inferred relationship Some
Product containing precisely pazopanib 200 milligram/1 each conventional release oral tablet Has active ingredient False Pazopanib (substance) Inferred relationship Some 1
Product containing precisely pazopanib 200 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Pazopanib (substance) Inferred relationship Some 1
Product containing precisely pazopanib 400 milligram/1 each conventional release oral tablet Has active ingredient False Pazopanib (substance) Inferred relationship Some 1
Product containing precisely pazopanib 400 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Pazopanib (substance) Inferred relationship Some 1
Pazopanib hydrochloride (substance) Is a False Pazopanib (substance) Inferred relationship Some
Product containing precisely pazopanib 400 milligram/1 each conventional release oral tablet Has precise active ingredient False Pazopanib (substance) Inferred relationship Some 1
Product containing precisely pazopanib 200 milligram/1 each conventional release oral tablet Has precise active ingredient False Pazopanib (substance) Inferred relationship Some 1
Product containing pazopanib in oral dose form (medicinal product form) Has active ingredient True Pazopanib (substance) Inferred relationship Some 1
Pazopanib hydrochloride (substance) Is modification of (attribute) True Pazopanib (substance) Inferred relationship Some
Product containing only pazopanib (medicinal product) Has active ingredient True Pazopanib (substance) Inferred relationship Some 1
Product containing only pazopanib in oral dose form (medicinal product form) Has active ingredient True Pazopanib (substance) Inferred relationship Some 1
Product containing precisely pazopanib (as pazopanib hydrochloride) 200 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Pazopanib (substance) Inferred relationship Some 1
Product containing precisely pazopanib (as pazopanib hydrochloride) 400 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Pazopanib (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start